```json
{
  "treatment_information": [
    {
      "treatment_type": "medication",
      "specific_treatment": "l-Thyroxine (l-T4)",
      "start_date": "Not specified",
      "end_date": "Not specified",
      "dosage_or_details": "Not specified",
      "treatment_response": "Administered due to congenital hypopituitarism with undetectable serum levels of GH, PRL, and TSH."
    },
    {
      "treatment_type": "medication",
      "specific_treatment": "Growth Hormone therapy",
      "start_date": "2000-01-01",  // Approximate estimation based on age 4.8
      "end_date": "2018-01-01",    // Approximate estimation based on age 18
      "dosage_or_details": "Not specified",
      "treatment_response": "Administered after blunted GH responses in stimulation tests."
    }
  ],
  "treatment_timeline": [
    {
      "date": "2001-01-01",
      "event": "Congenital hypopituitarism diagnosed at age 1 month."
    },
    {
      "date": "2002-01-01",
      "event": "Started on l-T4 due to undetectable serum GH, PRL, and TSH."
    },
    {
      "date": "2006-01-01",
      "event": "Commenced GH therapy at age 4.8 due to blunted GH responses observed."
    },
    {
      "date": "2018-01-01",
      "event": "GH therapy concluded after patient reached 18 years of age."
    }
  ]
}
```